Vincogen Corp

Vincogen Corp, established in 2001 and based in Philadelphia, PA, specializes in AI-based precision medicine through its innovative VincoAI platform. This generative AI technology accurately produces peptide-protein amino acid sequences for various applications, including biologics research, antimicrobial resistance, and drug delivery systems.

By leveraging advanced LSTM and Transformer models, Vincogen aims to streamline the discovery of preclinical candidates, ultimately enhancing the quality of life through personalized precision medicine. The company actively engages in the scientific community, presenting its research at major conferences and symposiums both domestically and internationally.

Generated from the website